Neuronal histamine deficit in Alzheimer's disease

被引:0
|
作者
Panula, P
Rinne, J
Kuokkanen, K
Eriksson, K
Sallmen, T
Kalimo, H
Relja, M
机构
[1] UNIV TURKU,DEPT NEUROL,FIN-20520 TURKU,FINLAND
[2] UNIV TURKU,DEPT PATHOL,FIN-20520 TURKU,FINLAND
关键词
hippocampus; tuberomammillary nucleus; hypothalamus; carbodiimide;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Histamine is known to be a neurotransmitter in the brain, but it has not been clearly implicated in major diseases. AII histaminergic neurons reside in the posterior hypothalamus and innervate most brain areas, which is compatible with the concept that histamine is involved in general central regulatory mechanisms. A sensitive high-performance liquid chromatographic fluorimetric method was used to measure histamine contents in post mortem Alzheimer brains and age-matched controls. The cellular storage sites and distribution of histaminergic nerve fibers were examined with a specific immunohistochemical method. The histamine content was significantly reduced in the hypothalamus (42% of control value), hippocampus (43%) and temporal cortex (53%) of Alzheimer brains. Differences in other cortical areas, putamen and substantia nigra were not significant. Histamine-containing nerve fibers were found in the hippocampus, parahippocampal gyrus and subiculum of both Alzheimer brains and controls. No histamine-containing mast cells were seen in these temporal structures. Histamine in the human temporal lobe is stored in nerve fibers originating from the posterior hypothalamus, and not in mast cells. Decrease in brain histamine may contribute to the cognitive decline in Alzheimer's disease directly or through the cholinergic system. Development of drugs that penetrate the blood-brain barrier and increase histaminergic activity might be beneficial in Alzheimer's disease. (C) 1997 IBRO. Published by Elsevier Science Ltd.
引用
收藏
页码:993 / 997
页数:5
相关论文
共 50 条
  • [41] Histamine H3 receptors in Alzheimer's disease
    Lim, C. Y.
    Lai, M. K.
    Wong, P. T.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 74 - 74
  • [42] Neuronal expression of myeloperoxidase is increased in Alzheimer's disease
    Green, PS
    Mendez, AJ
    Jacob, JS
    Crowley, J
    Tansey, M
    Growdon, W
    Hyman, BT
    Heinecke, JW
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S123 - S123
  • [43] Vulnerability of select neuronal types to Alzheimer's disease
    Braak, H
    Del Tredici, K
    Schultz, C
    Braak, E
    ALZHEIMERS DISEASE: A COMPENDIUM OF CURRENT THEORIES, 2000, 924 : 53 - 61
  • [44] Neuronal hyperactivity - A key defect in Alzheimer's disease?
    Busche, Marc Aurel
    Konnerth, Arthur
    BIOESSAYS, 2015, 37 (06) : 624 - 632
  • [45] Neuronal and Vascular Oxidative Stress in Alzheimer's Disease
    Massaad, Cynthia A.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 (04) : 662 - 673
  • [46] Evolution of neuronal changes in the course of Alzheimer's disease
    Braak, H
    Braak, E
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (53): : 127 - 140
  • [47] Evidence for neuronal oxidative damage in Alzheimer's disease
    Good, PF
    Werner, P
    Hsu, A
    Olanow, CW
    Perl, DP
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (01): : 21 - 28
  • [48] Neuronal hypertrophy in asymptomatic Alzheimer's Disease in the BLSA
    Iacono, Diego
    O'Brien, Richard
    Resnick, Susan M.
    Zonderman, Alan
    Pletnikova, Olga
    Rudow, Gay
    Yang, An
    West, Mark J.
    Crain, Barbara
    Troncoso, Juan C.
    FASEB JOURNAL, 2008, 22
  • [49] Mitochondrial dysfunction and neuronal apoptosis in Alzheimer's disease
    Takuma, Kazuhiro
    Fukuzaki, Emiko
    Nagai, Taku
    Mizoguchi, Hiroyuki
    Stern, David M.
    Yan, Shirley ShiDu
    Yamada, Kiyofumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 45P - 45P
  • [50] Neuronal activity and genetic background in Alzheimer's disease
    Salehi, A
    Dubelaar, EJG
    Ishunina, TA
    Swaab, DF
    ALZHEIMER'S DISEASE AND RELATED DISORDERS: ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 1999, : 487 - 492